In the experimental models of cholestatic fibrosis including BDL and Mdr2−/− mice, Msln-deficiency exhibited a significant suppressive effect on the progression of liver fibrosis by ≈50% decrease in myofibroblast infiltration. The gene discussed is MSLN; the disease is Hepatic fibrosis.